CBP /β‐Catenin Signaling in Hepatocytes Plays Pivotal Roles in MMP ‐7‐Mediated Liver Fibrosis in a Metabolic Dysfunction‐Associated Steatohepatitis Mouse Model
The FASEB Journal · 31.03.2026 · 40 (6)
DOI: 10.1096/fj.202504510r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 12.03.2026. Verfasst von Jun Imamura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: beta Catenin, Matrix Metalloproteinase 7, Hepatocytes, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
In this study, we focused on CBP/β‐catenin signaling in hepatocytes and investigated its involvement in fibrosis in a metabolic dysfunction‐associated steatohepatitis (MASH) model using a choline‐deficient, L‐amino acid‐defined, high‐fat diet (CDAHFD). Alb‐Cre/CBPKO (CBP hep‐KO ), Alb‐Cre/P300KO (P300 hep‐KO ), and Alb‐Cre mice were fed CDAHFD for 4 months, and liver tissue was used for Sirius Red staining. After 4 months of feeding, the CDAHFD CBP hep‐KO mice showed a significant decrease in the liver fibrosis area compared to the other mice. RNA was extracted from the livers and analyzed for fibrosis‐related gene expression using RT‐PCR, PCR array, and RNA‐seq analysis. RNA‐seq analysis revealed a significant difference in MMP‐7 expression between the livers of CBP hep‐KO and P300 hep‐KO mice. Next, MMP‐7KO and control mice were fed CDAHFD for 4 months. The MMP‐7KO mice showed a significant decrease in the liver fibrosis area. The C57BL/6 mice were fed CDAHFD, and 4 months later, AAV8/ShMMP‐7 and AAV8/control (2 × 10 12 copies/mouse) were injected twice at 2‐week intervals, and fibrosis was assessed. The AAV8/ShMMP‐7 treatment reduced the fibrotic area and expression of Col1A1 and Col3A1 in the livers of CDAHFD‐fed mice. Thus, CBP/β‐catenin signaling in hepatocytes has been implicated in MASH fibrosis via MMP‐7, suggesting that MMP‐7 is a potential target for new anti‐fibrosis drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
- Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
ORCID-Profile: Kiminori Kimura
Förderung
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Imamura, J., Kimura, M., Otoyama, Y., Nishikawa, K., Kohara, M., & Kimura, K. (2026). CBP /β‐Catenin Signaling in Hepatocytes Plays Pivotal Roles in MMP ‐7‐Mediated Liver Fibrosis in a Metabolic Dysfunction‐Associated Steatohepatitis Mouse Model. The FASEB Journal, 40(6). https://doi.org/10.1096/fj.202504510r
Vancouver
Imamura J, Kimura M, Otoyama Y, Nishikawa K, Kohara M, Kimura K. CBP /β‐Catenin Signaling in Hepatocytes Plays Pivotal Roles in MMP ‐7‐Mediated Liver Fibrosis in a Metabolic Dysfunction‐Associated Steatohepatitis Mouse Model. The FASEB Journal. 2026;40(6). doi:10.1096/fj.202504510r
BibTeX
@article{Imamura2026,
author = {Imamura, Jun and Kimura, Masamichi and Otoyama, Yumi and Nishikawa, Koji and Kohara, Michinori and Kimura, Kiminori},
title = {CBP /β‐Catenin Signaling in Hepatocytes Plays Pivotal Roles in MMP ‐7‐Mediated Liver Fibrosis in a Metabolic Dysfunction‐Associated Steatohepatitis Mouse Model},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {6},
doi = {10.1096/fj.202504510r}
}
EUVIMED